Imatinib treatment via intravesical infusion in CYP-induced cystitis did not affect urinary inflammatory mediator expression at the examined time point but could be utilizing other mechanisms to mediate functional improvements including altering urothelial barrier properties. This evidence concerns the gene PPIG and chronic cystitis.